Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Pontecorvo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2009
The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experienceA P Carpenter, M J Pontecorvo, F F Hefti, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1986
Behavioral recovery following bilateral lesions of the nucleus basalis does not occur spontaneouslyR T Bartus, M J Pontecorvo, C Flicker, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1986
A system for assessing toxicity of chemicals by continuous monitoring of homecage behaviorsH L Evans, P J Bushnell, J D Taylor, et al.
Brain Research Bulletin|March 1, 1991
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agentsM J Pontecorvo, E W Karbon, S Goode, et al.
Neurology|March 1, 1990
Dextromethorphan for treatment of complex partial seizuresR S Fisher, B J Cysyk, R P Lesser, et al.
Neurobiology of Aging|January 1, 1989
Individual differences in aging: behavioral and neurobiological correlatesA L Markowska, W S Stone, D K Ingram, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profileE W Karbon, M E Abreu, R H Erickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profileD B Clissold, M J Pontecorvo, B E Jones, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 12, 2013
Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomographyPaul B Rosenberg, D F Wong, S L Edell, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2009
The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experienceA P Carpenter, M J Pontecorvo, F F Hefti, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1986
Behavioral recovery following bilateral lesions of the nucleus basalis does not occur spontaneouslyR T Bartus, M J Pontecorvo, C Flicker, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1986
A system for assessing toxicity of chemicals by continuous monitoring of homecage behaviorsH L Evans, P J Bushnell, J D Taylor, et al.
Brain Research Bulletin|March 1, 1991
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agentsM J Pontecorvo, E W Karbon, S Goode, et al.
Neurology|March 1, 1990
Dextromethorphan for treatment of complex partial seizuresR S Fisher, B J Cysyk, R P Lesser, et al.
Neurobiology of Aging|January 1, 1989
Individual differences in aging: behavioral and neurobiological correlatesA L Markowska, W S Stone, D K Ingram, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profileE W Karbon, M E Abreu, R H Erickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profileD B Clissold, M J Pontecorvo, B E Jones, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 12, 2013
Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomographyPaul B Rosenberg, D F Wong, S L Edell, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
Pageof 2